Treatment of non-albicans Candida vaginitis with amphotericin B vaginal suppositories

Am J Obstet Gynecol. 2005 Jun;192(6):2009-12; discussion 2012-3. doi: 10.1016/j.ajog.2005.03.034.

Abstract

Objective: This study was undertaken to investigate whether amphotericin B vaginal suppositories would be effective in the treatment of non- albicans Candida vaginitis in women who failed conventional therapy.

Study design: Thirty-two patients were identified with non- albicans Candida vaginitis. These patients were treated with conventional antifungal agents. Ten patients had persistence of the non- albicans Candida infection after treatment. Amphotericin B 50-mg vaginal suppositories were given nightly for 14 days to this subgroup of treatment failures.

Results: Of 10 women, 8 (80%) who were treated with amphotericin B vaginally initially showed no further infection. One of the treatment successes had 2 recurrences and responded to a second course of amphotericin B but failed a third course. If this patient is considered a treatment failure, then amphotericin B vaginal suppositories were successful in 70% of patients. The medication was well tolerated and local side effects were minimal.

Conclusion: Amphotericin B vaginal suppositories are a viable treatment option for refractory vaginitis caused by non- albicans Candida .

Publication types

  • Clinical Trial

MeSH terms

  • Administration, Intravaginal
  • Adult
  • Aged
  • Amphotericin B / administration & dosage*
  • Antifungal Agents / administration & dosage*
  • Candida / classification
  • Candidiasis, Vulvovaginal / drug therapy*
  • Candidiasis, Vulvovaginal / pathology
  • Female
  • Humans
  • Middle Aged
  • Treatment Outcome

Substances

  • Antifungal Agents
  • Amphotericin B